V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220820 | 20156587 | null | null | null | null | 2018-12-02 | null | null | null | FLUOROURACIL + MITOMYCIN + RT | 101817856 |
| 20220833 | 20156588 | null | null | null | null | 2019-08-22 | null | null | null | CAPECITABINE + TEMOZOLOMIDE | 101740835 |
| 20220842 | 20156589 | null | null | null | null | 2018-07-02 | null | null | null | IMATINIB | 100089777 |
| 20220846 | 20156590 | 1.58 | 95 | Adjuvant (A) | 2018-11-04 | 2018-11-09 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | PLATFORM TRIAL | 100709450 |
| 20220864 | 20156591 | null | null | Palliative (P) | null | 2018-09-06 | null | null | N | CETUXIMAB + OXALIPLATIN + MDG | 100086352 |
| 20220871 | 20156592 | null | null | Adjuvant (A) | null | 2021-01-01 | IMATINIB | 02 | Y | IMATINIB | 100997186 |
| 20220875 | 20156593 | null | 53 | Palliative (P) | null | 2019-10-05 | null | null | N | PLATFORM TRIAL | 100082521 |
| 20220886 | 20156595 | null | null | Palliative (P) | 2021-05-03 | 2021-05-16 | CETUXIMAB + OXALIPLATIN + MDG | N | N | CETUXIMAB + OXALIPLATIN + MDG | 101791976 |
| 20220890 | 20156596 | null | null | null | null | 2018-08-08 | null | null | null | FLUOROURACIL + MITOMYCIN + RT | 100182854 |
| 20220896 | 20156597 | 1.8 | 51 | null | null | 2016-09-24 | null | null | null | CARBOPLATIN + GEMCITABINE | 100136464 |
| 20220920 | 20156600 | 1.76 | 67 | Palliative (P) | 2017-04-02 | 2017-06-13 | PLATFORM Trial | 01 | N | PLATFORM TRIAL | 101122307 |
| 20220923 | 20156601 | 1.64 | 0 | null | 2018-11-30 | 2018-12-28 | Imatinib 400mg | 02 | null | IMATINIB | 100021300 |
| 20220929 | 20156602 | 1.71 | 72.9 | Palliative (P) | null | 2018-02-21 | null | null | N | FLUOROURACIL + MITOMYCIN + RT | 100099103 |
| 20220945 | 20156605 | 1.65 | 100 | null | null | 2016-08-05 | null | null | null | PLATFORM TRIAL | 100274288 |
| 20220947 | 20156606 | 1.66 | 88 | null | 2018-05-13 | 2018-05-15 | null | null | null | CARBOPLATIN + GEMCITABINE | 101816265 |
| 20220959 | 20156607 | 1.68 | 95 | null | 2017-04-01 | 2017-04-22 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100588250 |
| 20220996 | 20156609 | 1.88 | 76.6 | null | 2017-01-04 | 2017-04-19 | null | null | null | RALTITREXED | 101819144 |
| 20221021 | 20156611 | 1.8 | 149 | Palliative (P) | 2016-02-24 | 2016-02-24 | null | null | N | PLATFORM TRIAL | 100287460 |
| 20221029 | 20156612 | 1.54 | 82.6 | null | 2016-05-22 | 2016-05-30 | null | null | null | CETUXIMAB + OXALIPLATIN + MDG | 100439583 |
| 20221041 | 20156613 | null | 92.2 | Palliative (P) | 2016-01-13 | 2016-05-24 | null | null | N | REGORAFENIB | 100527791 |
| 20221057 | 20156615 | 1.78 | 81.05 | null | 2019-06-14 | 2019-12-21 | null | null | null | REGORAFENIB | 100264853 |
| 20221064 | 20156616 | 1.64 | 77.8 | Adjuvant (A) | 2016-04-07 | 2016-04-07 | null | null | N | RALTITREXED | 101068629 |
| 20221079 | 20156618 | 1.63 | 70.9 | null | null | 2021-06-07 | IMATINIB | 02 | null | IMATINIB | 101699760 |
| 20221095 | 20156619 | 1.75 | 95.15 | Neo-adjuvant (N) | 2016-05-06 | 2016-06-23 | null | null | N | RALTITREXED | 101445003 |
| 20221103 | 20156620 | 1.6 | 80.6 | Curative (C) | 2016-05-14 | 2016-05-14 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101482232 |
| 20221104 | 20156621 | null | 54.2 | null | 2017-04-12 | 2017-04-18 | null | null | null | CARBOPLATIN | 100266547 |
| 20221110 | 20156622 | null | null | null | 2018-11-24 | 2019-02-20 | null | null | null | CARBOPLATIN | 101718312 |
| 20221118 | 20156623 | 1.6 | 72.75 | Palliative (P) | 2017-01-30 | 2017-01-30 | null | null | N | IMATINIB | 100595490 |
| 20221123 | 20156624 | 1.76 | 79.1 | Curative (C) | null | 2021-09-13 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101807708 |
| 20221151 | 20156627 | null | null | null | 2019-09-02 | 2019-09-02 | null | null | null | FLUOROURACIL + MITOMYCIN + RT | 101329686 |
| 20221158 | 20156628 | 1.77 | 70.6 | Palliative (P) | 2017-04-30 | 2017-06-20 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101123278 |
| 20221160 | 20156629 | 1.76 | 79 | Palliative (P) | 2020-01-02 | 2020-03-08 | null | null | N | RALTITREXED | 100619488 |
| 20221166 | 20156630 | 1.69 | 61.8 | Adjuvant (A) | 2018-07-06 | 2018-10-29 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100055350 |
| 20221170 | 20156631 | 1.73 | 69.6 | null | null | 2018-01-12 | null | null | null | PLATFORM TRIAL | 100327769 |
| 20221187 | 20156633 | 1.67 | 106.4 | Neo-adjuvant (N) | 2018-03-11 | 2018-03-18 | null | null | N | FLUOROURACIL + MITOMYCIN + RT | 100101027 |
| 20221210 | 20156634 | 1.75 | 100.7 | Palliative (P) | 2018-09-29 | 2018-10-08 | REGORAFENIB | 02 | N | REGORAFENIB | 100661204 |
| 20221214 | 20156635 | 1.71 | 54.7 | Palliative (P) | 2016-03-11 | 2016-07-18 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 101169388 |
| 20221282 | 20156638 | 1.5 | 97.9 | null | 2015-07-31 | 2016-04-05 | null | null | null | CETUXIMAB + OXALIPLATIN + MDG | 101366827 |
| 20221295 | 20156639 | 1.81 | 57.95 | null | null | 2018-09-09 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101301235 |
| 20221297 | 20156640 | 1.81 | 44 | null | 2017-10-20 | 2017-10-21 | null | null | null | CARBOPLATIN + GEMCITABINE | 100123939 |
| 20221303 | 20156642 | 1.79 | 61 | null | 2019-07-08 | 2019-07-09 | null | null | null | CETUXIMAB + OXALIPLATIN + MDG | 101312143 |
| 20221322 | 20156644 | 1.51 | 47 | Adjuvant (A) | 2018-08-06 | 2018-08-06 | REGORAFENIB | 02 | N | REGORAFENIB | 100357075 |
| 20221335 | 20156646 | 1.8 | 107.3 | null | 2019-01-14 | 2019-01-14 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101312593 |
| 20221365 | 20156647 | 1.78 | 78 | null | 2020-12-23 | 2021-05-07 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100501237 |
| 20221377 | 20156648 | null | null | Palliative (P) | 2018-04-11 | 2018-04-13 | null | null | N | CARBOPLATIN | 100325903 |
| 20221483 | 20156651 | 1.72 | 80.7 | Palliative (P) | 2019-06-09 | 2020-03-25 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100896888 |
| 20221496 | 20156653 | 1.66 | 66.95 | null | 2016-08-30 | 2016-09-15 | null | null | null | CETUXIMAB + OXALIPLATIN + MDG | 100410223 |
| 20221539 | 20156654 | 1.63 | null | Palliative (P) | 2017-12-25 | 2018-01-06 | Imatinib 400mg | 02 | N | IMATINIB | 101593640 |
| 20221557 | 20156656 | 1.67 | 57 | null | 2016-02-26 | 2016-02-26 | null | null | null | CARBOPLATIN + GEMCITABINE | 100470260 |
| 20221582 | 20156657 | 1.67 | 69.7 | null | 2018-01-09 | 2018-01-14 | Raltitrexed | N | null | RALTITREXED | 101678723 |